4B24.1ICD-11 MMS 2026-01
Chronic graft-versus-host disease
Description
Chronic graft-versus-host disease (GVHD) presents more than 100 days after engraftment of immunocompetent donor lymphoid cells. It has specific clinical features by which it can be distinguished from acute GVHD. It may arise de novo but frequently follows acute GVHD. Less commonly, it occurs concurrently with acute GVHD. The earlier stages of chronic GVHD are characterised by a widespread lichenoid rash, poikiloderma and involvement of nails and oral mucous membranes. If the disease remains active, progressive sclerosis of the skin and deeper tissues may result in joint contractures, fibrosis of internal organs and severe malabsorption.
Index terms
- Chronic graft-versus-host disease
- chronic GVHD - [graft-versus-host disease]
- chronic graft-versus-host-disease
Show allHide
- Early chronic graft-versus-host disease
- Chronic lichenoid graft-versus-host disease
- chronic lichenoid GVHD - [graft-versus-host disease]
- early chronic GVHD - [graft-versus-host disease]
- Late chronic graft-versus-host disease
- Sclerodermatous chronic graft-versus-host disease
- late chronic GVHD - [graft-versus-host disease]
- sclerodermatous GVHD - [graft-versus-host disease]
- sclerodermatous graft-versus-host disease
Exclusions from above levels
Sibling codes
Foundation entity
Chronic graft-versus-host disease – http://id.who.int/icd/entity/621183043
Allowed postcoordination axes
Part of: 4B24: Graft-versus-host disease › 04: Diseases of the immune system